Crescita Therapeutics Finalizes Acquisition by ClinActiv Holdings
Deal Finalization Crescita Therapeutics Inc., a commercial dermatology company based in Laval, Québec, officially finalized its acquisition by ClinActiv Holdings Inc. this week. Under the terms of the arrangement, ClinActiv’s subsidiary acquired all issued and outstanding common shares of Crescita for a cash consideration of $0.80 per share. The transaction marks the conclusion of a…